FDA Recalls · August 27, 2026 · Primary source
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
Summary
B. Braun Medical Inc. voluntarily recalled three lots of 0.9% Sodium Chloride Injection USP, 100 mL (in 150 mL PAB containers), to the hospital and healthcare facility level due to the presence of particulate matter. The recall was announced August 19, 2026 and applies nationwide. The action is a product-safety recall with direct implications for hospital pharmacy and supply-chain operations but no Medicare/Medicaid billing, fraud-and-abuse, or behavioral health compliance dimension.
What this may mean
Hospitals, healthcare facilities, and users that received the affected lots must identify and quarantine or return the recalled product. The recall does not trigger Medicare billing, AKS, FCA, or behavioral health regulatory obligations, but facilities must manage supply-chain disruption and patient safety reporting for any adverse events linked to the recalled lots. No financial penalty or enforcement action against a provider is disclosed.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- FDA Recalls · August 20, 2026Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin LevelsScore 68
- FDA Recalls · August 24, 2026Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super PotencyScore 50
- FDA Recalls · October 7, 2026Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital MeterScore 48
- FDA Recalls · September 4, 2026American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of SterilityScore 46
- FDA Recalls · August 25, 2026Baxter Issues Voluntary Nationwide Recall for One Lot of 70% Dextrose Injection Due to Potential Presence of Particulate MatterScore 43
- FDA Recalls · August 20, 2026B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate MatterScore 43